Research Analysts Set Expectations for LXEO Q1 Earnings
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Lexeo Therapeutics in a research report issued on Monday, March 24th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings per share of ($0.80) for the quarter. The consensus […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for Lexeo Therapeutics in a research report issued on Monday, March 24th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings per share of ($0.80) for the quarter. The consensus […]
